213 related articles for article (PubMed ID: 38441807)
21. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.
Bindoli S; Baggio C; Doria A; Sfriso P
Drugs; 2024 Mar; 84(3):257-274. PubMed ID: 38441807
[TBL] [Abstract][Full Text] [Related]
22. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
23. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
24. Adult-onset Still's disease: Advances in the treatment.
Castañeda S; Blanco R; González-Gay MA
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
[TBL] [Abstract][Full Text] [Related]
25. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
[TBL] [Abstract][Full Text] [Related]
26. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
Sfriso P; Bindoli S; Galozzi P
Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
[TBL] [Abstract][Full Text] [Related]
27. Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease.
Kim DH; Lee KJ; Park J; Chi S; Han J; Bang Y; Kim SM; Kang SG; Cha SH; Han YH
Biomed Pharmacother; 2023 Nov; 167():115587. PubMed ID: 37774670
[TBL] [Abstract][Full Text] [Related]
28. IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome.
Baggio C; Bindoli S; Guidea I; Doria A; Oliviero F; Sfriso P
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446301
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function.
Hakim AD; Awili M; O'Neal HR; Siddiqi O; Jaffrani N; Lee R; Overcash JS; Chauffe A; Hammond TC; Patel B; Waters M; Criner GJ; Pachori A; Junge G; Levitch R; Watts J; Koo P; Sengupta T; Yu L; Kiffe M; Pinck A; Stein RR; Bendrick-Peart J; Jenkins J; Rowlands M; Waldron-Lynch F; Matthews J
Clin Exp Immunol; 2023 Oct; 213(3):265-275. PubMed ID: 37338154
[TBL] [Abstract][Full Text] [Related]
30. IL-18 Binding Protein-Producing Cells Attenuate Anemia in Murine Macrophage Activation Syndrome.
Harel M; Fauteux-Daniel S; Rodriguez E; Palmer G; Gabay C
J Immunol; 2023 Jun; 210(11):1790-1803. PubMed ID: 37074208
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.
Sun Z; Li R; Wang Y; Han F; Wei W; Li X
Drugs R D; 2023 Jun; 23(2):109-120. PubMed ID: 37010773
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of emapalumab in macrophage activation syndrome.
De Benedetti F; Grom AA; Brogan PA; Bracaglia C; Pardeo M; Marucci G; Eleftheriou D; Papadopoulou C; Schulert GS; Quartier P; Antón J; Laveille C; Frederiksen R; Asnaghi V; Ballabio M; Jacqmin P; de Min C
Ann Rheum Dis; 2023 Jun; 82(6):857-865. PubMed ID: 37001971
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review).
Zhang X; Wang Z; Zheng Y; Yu Q; Zeng M; Bai L; Yang L; Guo M; Jiang X; Gan J
Int J Mol Med; 2023 Apr; 51(4):. PubMed ID: 36960868
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and outcome of elderly onset adult-onset Still's disease: A 10-year retrospective study.
Li S; Ying S; Bai J; Wang Y; Yang C; Sun Q; Fang H; Qiao J
J Transl Autoimmun; 2023; 6():100196. PubMed ID: 36923474
[TBL] [Abstract][Full Text] [Related]
35. Proposal of a new diagnostic algorithm for adult-onset Still's disease.
Daghor-Abbaci K; Ait Hamadouche N; Makhloufi CD; Mechid F; Otmani F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
Clin Rheumatol; 2023 Apr; 42(4):1125-1135. PubMed ID: 36694091
[TBL] [Abstract][Full Text] [Related]
36. Systematic review on the use of biologics in adult-onset still's disease.
Fautrel B; Patterson J; Bowe C; Arber M; Glanville J; Mealing S; Canon-Garcia V; Fagerhed L; Rabijns H; Giacomelli R
Semin Arthritis Rheum; 2023 Feb; 58():152139. PubMed ID: 36442231
[TBL] [Abstract][Full Text] [Related]
37. Performance of the modified Systemic Manifestation Score for systemic juvenile idiopathic arthritis in Adult-onset Still's disease.
Zhu D; Meng J; Jia J; Wang M; Ma Y; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Wang Z; Wan L; Zhou Z; Wang F; Chen X; Yang C; Hu Q; Teng J
Clin Rheumatol; 2023 Jan; 42(1):187-195. PubMed ID: 36028637
[TBL] [Abstract][Full Text] [Related]
38. Development of Pulmonary Alveolar Proteinosis in a Patient With Adult-Onset Still Disease Treated With Tocilizumab.
Ito Y; Nakahara H; Nakajima A
J Rheumatol; 2023 Feb; 50(2):288-289. PubMed ID: 35970533
[No Abstract] [Full Text] [Related]
39. Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still's disease: A STROBE-Compliant prospective observational study.
Daghor Abbaci K; Ait Hamadouche N; Otmani F; Dahou Makhloufi C; Mechid F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
Medicine (Baltimore); 2022 Aug; 101(32):e29970. PubMed ID: 35960098
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
